• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[长期对比研究:双氯芬酸(扶他林)与萘普生(甲氧萘丙酸)治疗关节炎]

[Long-term comparative study: diclofenac (voltaren) and naproxen (proxen) in arthritis].

作者信息

Siegmeth W, Placheta P

出版信息

Schweiz Med Wochenschr. 1978 Mar 4;108(9):349-53.

PMID:625655
Abstract

Two non-steroidal antirheumatic drugs, diclofenac (Voltaren) and naproxen (Proxen), were compared with respect to their analgesic effect and the observed improvement in joint mobility in two groups of patients, each consisting of 20 males with either cox-arthrosis or gonarthrosis. The duration of treatment was up to six months. The therapeutic response was assessed by the mean scores of spontaneous and exercise-induced pain, the clinical state of joints and painfree time of walking. Both drugs led to a persistent improvement in the condition of most patients, but the clinical impression would appear to point to a more marked analgesic effect of diclofenac. The daily maintenance dosage from the fourth week of treatment onwards was 75 mg diclofenac and 500 mg naproxen. Both drugs were generally well tolerated. Occasionally gastrointestinal side effects were observed (more frequently in the naproxen group). Laboratory controls were carried out periodically, but no evidence of organ toxicity or hemotoxic effects was found.

摘要

在两组患者中比较了两种非甾体类抗风湿药物双氯芬酸(扶他林)和萘普生(甲氧萘丙酸)的镇痛效果以及观察到的关节活动度改善情况。每组由20名患有髋关节炎或膝关节炎的男性组成。治疗持续时间长达6个月。通过自发疼痛和运动诱发疼痛的平均评分、关节的临床状态以及无痛行走时间来评估治疗反应。两种药物都使大多数患者的病情持续改善,但临床印象似乎表明双氯芬酸的镇痛效果更显著。从治疗第四周起,每日维持剂量为双氯芬酸75毫克和萘普生500毫克。两种药物总体耐受性良好。偶尔观察到胃肠道副作用(在萘普生组中更常见)。定期进行实验室检查,但未发现器官毒性或血液毒性作用的证据。

相似文献

1
[Long-term comparative study: diclofenac (voltaren) and naproxen (proxen) in arthritis].[长期对比研究:双氯芬酸(扶他林)与萘普生(甲氧萘丙酸)治疗关节炎]
Schweiz Med Wochenschr. 1978 Mar 4;108(9):349-53.
2
Comparative clinical trials with diclofenac sodium (Voltarol) and naproxen in rheumatic conditions: investigation of possible changes in diclofenac dose and dose interval.
Rheumatol Rehabil. 1979;Suppl 2:69-74.
3
Diclofenac (Voltaren) for the treatment of osteo-arthrosis: a double-blind comparison with naproxen.双氯芬酸(扶他林)治疗骨关节炎:与萘普生的双盲对照研究
J Int Med Res. 1977;5(3):169-74. doi: 10.1177/030006057700500305.
4
The value and results of long-term studies with diclofenac sodium (Voltarol).双氯芬酸钠(扶他林)长期研究的价值与结果。
Rheumatol Rehabil. 1979;Suppl 2:100-15.
5
[Comparative efficacy of voltaren and naproxen in rheumatoid arthritis (double-blind trial)].
Ter Arkh. 1981;53(7):111-4.
6
An open assessment of the efficacy and tolerability of diclofenac sodium (Voltarol) in patients with rheumatic disease and a comparative study of diclofenac sodium (Voltarol) with indomethacin in patients with osteoarthritis and rheumatoid arthritis.
Rheumatol Rehabil. 1979;Suppl 2:81-8.
7
Diclofenac sodium (Voltaren) and naproxen in the treatment of rheumatoid arthritis: a comparative double-blind study.
Scand J Rheumatol Suppl. 1978(22):57-62. doi: 10.3109/03009747809097218.
8
Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.依托考昔:新药。避免使用环氧化酶-2抑制剂止痛。
Prescrire Int. 2007 Dec;16(92):223-7.
9
[Comparative double-blind trial of diclophenac-sodium and naproxen in hip arthrosis].双氯芬酸钠与萘普生治疗髋关节炎的比较双盲试验
Reumatizam. 1981;28(6):193-6.
10
Comparisons of tolerability findings in international clinical trials.
Rheumatol Rehabil. 1979;Suppl 2:122-34.

引用本文的文献

1
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.双氯芬酸钠。对其药效学和药代动力学特性以及治疗效果的重新评估。
Drugs. 1988 Mar;35(3):244-85. doi: 10.2165/00003495-198835030-00004.
2
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.萘普生最新进展:对其药理特性、治疗效果以及在风湿性疾病和疼痛状态中的应用的综述。
Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001.